Publishing research using ab32039? Please let us know so that we can cite the reference in this datasheet.
ab32039 has been referenced in 5 publications.
- Liu Y et al. ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma. Cancer Cell Int 19:32 (2019). PubMed: 30814910
- Mamand S et al. Comparison of interleukin-2-inducible kinase (ITK) inhibitors and potential for combination therapies for T-cell lymphoma. Sci Rep 8:14216 (2018). PubMed: 30242208
- Carson CC et al. IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma. Clin Cancer Res 21:2167-76 (2015). Human . PubMed: 25934889
- Schiralli Lester GM et al. Interleukin 2-inducible T cell kinase (ITK) facilitates efficient egress of HIV-1 by coordinating Gag distribution and actin organization. Virology 436:235-43 (2013). PubMed: 23260110
- Stepensky P et al. IL-2-inducible T-cell kinase deficiency: clinical presentation and therapeutic approach. Haematologica 96:472-6 (2011). WB ; Human . PubMed: 21109689